Top

Published in:

Open Access 01-08-2018 | Original Communication

Depressive symptoms in stroke patients treated and non-treated with intravenous thrombolytic therapy: a 1-year follow-up study

Authors: Barbara Grabowska-Fudala, Krystyna Jaracz, Krystyna Górna, Izabela Miechowicz, Izabela Wojtasz, Jan Jaracz, Radosław Kaźmierski

Published in: Journal of Neurology | Issue 8/2018

Abstract

Introduction

This is a prospective study, first to compare the frequency of depressive symptoms in stroke survivors treated, and non-treated, with intravenous thrombolysis and second, to explore relationships between post-stroke depression (PSD) and stroke treatment modalities, taking into account other possible determinants of PSD, including post-traumatic stress symptoms.

Methods

Groups of 73 thrombolysed and 73 non-thrombolysed patients matched for age and gender were examined at 3 and 12 months after discharge. PSD was assessed using the Beck Depression Inventory. Post-traumatic stress symptoms (PTSS), disability and social support were assessed with the Impact of Event Scale-Revised, the Barthel Index and the Berlin Social Support Scale.

Results

At 3 months, PSD was present in 23.3% of the thrombolysed and 31.5% in the non-thrombolysed groups (p = 0.265). At 12 months, the frequencies were 29.2 and 20.6% (p = 0.229). Logistic regression of the combined group of thrombolysed and non-thrombolysed patients indicated that at 3 months, the adjusted predictors of PSD were disability (OR 24.35), presence of PTSS (OR 9.32), low social support (OR 3.68) and non-thrombolytic treatment (OR 3.19). At 12 months, the predictors were disability (OR 15.78) and low education (OR 3.61).

Limitations

The use of a questionnaire for the detection of depression, the relatively small sample size and a significant drop-out rate could limit the interpretation of these results.

Conclusions

(1) Thrombolysed and non-thrombolysed stroke survivors had similar frequency of depressive symptoms although the thrombolysed patients had more severe neurological deficits in the acute phase. It can be assumed that if thrombolysis had not been used, depressive symptoms would have been more frequent. (2) Lack of the rt-PA treatment was associated with three-time greater odds of screening for PSD at 3 months post-stroke, after adjustment for other PSD correlates. (3) Therefore, thrombolytic therapy seems to have a positive, but indirect, effect on patients’ mood, especially in the first months after stroke. (4) All stroke patients, irrespective of the method of treatment, should be monitored for the presence of depression.

National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581–1588CrossRef

IST-3 collaborative group (2013) Effect of thrombolysis with alteplase within six hours of acute ischaemic stroke on long-term outcomes (the Third International Stroke Trial [IST-3]): 18-month follow-up of a randomised controlled trial. Lancet Neurol 8:768–776

Rodier M, Quirié A, Prigent-Tessier A et al (2015) Relevance of post-stroke circulating BDNF levels as a prognostic biomarker of stroke outcome. Impact of rt-PA treatment. PLoS One 10:e0140668. https://doi.org/10.1371/journal.pone.0140668 CrossRefPubMedPubMedCentral

Rha JH, Saver JL (2007) The impact of recanalization on ischemic stroke outcome. Stroke 38:967–973. https://doi.org/10.1161/01.STR.0000258112.14918.24 CrossRefPubMed

Wardlaw JM, Murray V, Berge E, del Zoppo GJ (2014) Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev 7:CD000213PubMedCentral

Ayerbe L, Ayis S, Crichton S, Wolfe CD, Rudd AG (2013) The natural history of depression up to 15 years after stroke: the South London Stroke Register. Stroke 44:1105–1110CrossRefPubMed

Bartoli F, Lillia N, Lax A, Crocamo C, Mantero V, Carrà G, Agostoni E, Clerici M (2013) Depression after stroke and risk of mortality: a systematic review and meta-analysis. Stroke Res Treat 2013:862978. https://doi.org/10.1155/2013/862978 PubMedPubMedCentralCrossRef

Robinson RG, Jorge RE (2016) Post-stroke depression: a review. Am J Psychiatry 173:221–231. https://doi.org/10.1176/appi.ajp.2015.15030363 CrossRefPubMed

Kutlubaev MA, Hackett ML (2014) Part II: predictors of depression after stroke and impact of depression on stroke outcome: an updated systematic review of observational studies. Int J Stroke 9:1026–1036. https://doi.org/10.1111/IJS.12356 CrossRefPubMed

10.

Salter K, Mehta S, Cotoi A, Teasell R, Foley N, Serrato J, Speechley M (2016) Post stroke depression and mood disorders. Evidence-based review of stroke rehabilitation, 17th edn, last updated August 2016. http://www.ebrsr.com. Accessed 12 Jan 2017

11.

Schmitz ML, Simonsen CZ, Hundborg H, Christensen H, Ellemann K, Geisler K, Iversen H, Madsen C, Rasmussen MJ, Vestergaard K, Andersen G, Johnsen SP (2014) Acute ischemic stroke and long-term outcome after thrombolysis. Stroke 45:3070–3072. https://doi.org/10.1161/STROKEAHA.114.006570 CrossRefPubMed

12.

Stefanovic Budimkic M, Pekmezovic T, Beslac-Bumbasirevic L, Ercegovac M, Berisavac I, Stanarcevic P, Padjen V, Jovanović DR (2017) Long-term prognosis in ischemic stroke patients treated with intravenous thrombolytic therapy. J Stroke Cerebrovasc Dis 26:196–203. https://doi.org/10.1016/j.jstrokecerebrovasdis.2016.09.009 CrossRefPubMed

13.

de Weerd L, Luijckx GJR, Groenier KH, van der Meer K (2012) Quality of life of elderly ischaemic stroke patients one year after thrombolytic therapy. A comparison between patients with and without thrombolytic therapy. BMC Neurol 12:61CrossRefPubMedPubMedCentral

14.

Schwab-Malek S, Vatankhah B, Bogdahn U, Horn M, Audebert HJ (2010) Depressive symptoms and quality of life after thrombolysis in stroke: the TEMPiS study. J Neurol 257:1848–1854CrossRefPubMed

15.

Grabowska-Fudala B, Jaracz K, Górna K, Jaracz J, Kaźmierski R (2017) Clinical recovery and health-related quality of life in ischaemic stroke survivors receiving thrombolytic treatment: a 1-year follow-up study. J Thromb Thrombolysis 43:91–97. https://doi.org/10.1007/s11239-016-1419-3 CrossRefPubMed

16.

Ringleb PA, Bousser MG, Ford G, Bath P, Brainin M, Caso V (2008) European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack-2008. Cerebrovasc Dis 25:457–507. https://doi.org/10.1159/000131083 CrossRef

17.

Anemaet WK (2002) Using standardized measures to meet the challenge of stroke assessment. Top Geriatr Rehabil 18:47–62CrossRef

18.

Muchada M, Rubiera M, Rodriguez-Luna D, Pagola J, Flores A, Kallas J, Sanjuan E, Meler P, Alvarez-Sabin J, Ribo M, Molina CA (2014) Baseline National Institutes of Health stroke scale-adjusted time window for intravenous tissue-type plasminogen activator in acute ischemic stroke. Stroke 45:1059–1063. https://doi.org/10.1161/STROKEAHA.113.004307 CrossRefPubMed

19.

Collin C, Wade DT, Davies S, Horne V (1988) The Barthel ADL Index: a reliability study. Disabil Rehabil 10:61–63

20.

Legh-Smith J, Wade DT, Langton-Hewer R (1986) Services for stroke patients one year after stroke. J Epidemiol Community Health 40:161–165CrossRefPubMedPubMedCentral

21.

Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571CrossRefPubMed

22.

Parnowski TB, Jernajczyk W (1977) Inwentarz depresji Becka w ocenie nastroju osób zdrowych i chorych na choroby afektywne (ocena pilotażowa). Psychiatr Pol 11:417–425PubMed

23.

Juczyński Z, Ogińska-Bulik N (2009) Pomiar zaburzeń po stresie traumatycznym—polska wersja zrewidowanej skali wpływu zdarzeń. Psychiatria 6:1–8

24.

Weiss DS, Marmar CR (1997) The impact of event scale-revised. In: Wilson JP, Keane TM (eds) Assessing psychological trauma and PTSD. Guilford Press, New York, pp 399–411

25.

Creamer M, Bell R, Failla S (2003) Psychometric properties of the impact of event scale—revised. Behav Res Ther 41:1489–1496. https://doi.org/10.1016/j.brat.2003.07.010 CrossRefPubMed

26.

Bruggimann L, Annoni JM, Staub F, Von Steinbüchel N, Van der Linden M, Bogousslavsky J (2006) Chronic posttraumatic stress symptoms after nonsevere stroke. Neurology 66:513–516. https://doi.org/10.1212/01.wnl.0000194210.98757.49 CrossRefPubMed

27.

Deng LX, Khan AM, Drajpuch D, Fuller S, Ludmir J, Mascio CE, Partington SL, Qadeer A, Tobin L, Kovacs AH, Kim YY (2016) Prevalence and correlates of post-traumatic stress disorder in adults with congenital heart disease. Am J Cardiol 117:853–857. https://doi.org/10.1016/j.amjcard.2015.11.065 CrossRefPubMed

28.

Luszczynska A, Kowalska M, Mazurkiewicz M, Schwarzer R (2006) Berlin Social Support Scales (BSSS): Polish version of BSSS and preliminary results on its psychometric properties. Studia Psychologiczne (Psychol Stud) 3:17–27

29.

Łuszczyńska A, Kowalska M, Schwarzer R, Schulz U (2002) Berlin Social Support Scales (BSSS)—Polish Version. http://userpage.fu-berlin.de/~health/soc_pol.htm. Accessed 12 Jan 2017

30.

Hosmer DW, Lemeshow S (2000) Applied logistic regression, 2nd edn. Wiley, Hoboken, pp 91–143CrossRef

31.

El Husseini N, Goldstein LB, Peterson ED, Zhao X, Pan W, Olson DM, Zimmer LO, Williams JW, Bushnell C, Laskowitz DT (2012) Depression and antidepressant use after stroke and transient ischemic attack. Stroke 43:1609–1616. https://doi.org/10.1161/STROKEAHA.111.643130 CrossRefPubMed

32.

Eriksson M, Asplund K, Glader EL, Norrving B, Stegmayr B, Terént A, Asberg KH, Wester PO, Collaboration R-S (2004) Self-reported depression and use of antidepressants after stroke: a national survey. Stroke 35:936–941. https://doi.org/10.1161/01.STR.0000121643.86762.9a CrossRefPubMed

33.

Roese NJ (1994) The functional basis of counterfactual thinking. J Pers Soc Psychol 66:805–811CrossRef

34.

Amiri H, Bluhmki E, Bendszus M, Eschenfelder CC, Donnan GA, Leys D, Molina C, Ringleb PA, Schellinger PD, Schwab S, Toni D, Wahlgren NW (2016) European Cooperative Acute Stroke Study-4: extending the time for thrombolysis in emergency neurological deficits ECASS-4: ExTEND. Int J Stroke 11:260–267. https://doi.org/10.1177/1747493015620805 CrossRefPubMed

35.

Hackett ML, Pickles K (2014) Part I: frequency of depression after stroke: an updated systematic review and meta-analysis of observational studies. Int J Stroke 9:1017–1025. https://doi.org/10.1111/IJS.12357 CrossRefPubMed

36.

Hackett ML, Yapa C, Parag V, Anderson CS (2005) Frequency of depression after stroke: a systematic review of observational studies. Stroke 36:1330–1340. https://doi.org/10.1161/01.STR.0000165928.19135.35 CrossRefPubMed

37.

Kotila M, Numminen H, Waltimo O, Kaste M (1998) Depression after stroke: results of the FINNSTROKE Study. Stroke 29:368–372. https://doi.org/10.1161/01.STR.29.2.368 CrossRefPubMed

38.

Pohjasvaara T, Leppävuori A, Siira I, Vataja R, Kaste M, Erkinjuntti T (1998) Frequency and clinical determinants of poststroke depression. Stroke 29:2311–2317. https://doi.org/10.1161/01.STR.29.11.2311 CrossRefPubMed

39.

Ginzburg K, Ein-Dor T, Solomon Z (2010) Comorbidity of posttraumatic stress disorder, anxiety and depression: a 20-year longitudinal study of war veterans. J Affect Disord 123:249–257. https://doi.org/10.1016/j.jad.2009.08.006 CrossRefPubMed

40.

Goldfinger JZ, Edmondson D, Kronish IM, Fei K, Balakrishnan R, Tuhrim S, Horowitz CR (2014) Correlates of posttraumatic stress disorder in stroke survivors. J Stroke Cerebrovasc Dis 23:1099–1105. https://doi.org/10.1016/j.jstrokecerebrovasdis.2013.09.019 CrossRefPubMed

41.

Kiphuth IC, Utz KS, Noble AJ, Köhrmann M, Schenk T (2014) Increased prevalence of posttraumatic stress disorder in patients after transient ischemic attack. Stroke 45:3360–3366. https://doi.org/10.1161/STROKEAHA.113.004459 CrossRefPubMed

42.

Kiphuth IC, Utz Garton AL, Sisti JA, Gupta VP, Christophe BR, Connolly ES (2017) Poststroke post-traumatic stress disorder: a review. Stroke 48:507–512. https://doi.org/10.1161/STROKEAHA.116.015234 CrossRef

43.

Northcott S, Moss B, Harrison K, Hilari K (2016) A systematic review of the impact of stroke on social support and social networks: associated factors and patterns of change. Clin Rehabil 30:811–831. https://doi.org/10.1177/0269215515602136 CrossRefPubMed

44.

Cohen S, Wills TA (1985) Stress, social support, and the buffering hypothesis. Psychol Bull 98:310–357. https://doi.org/10.1037/0033-2909.98.2.310 CrossRefPubMed

45.

Nishiyama Y, Komaba Y, Ueda M, Nagayama H, Amemiya S, Katayama Y (2010) Early depressive symptoms after ischemic stroke are associated with a left lenticulocapsular area lesion. J Stroke Cerebrovasc Dis 19:184–189. https://doi.org/10.1016/j.jstrokecerebrovasdis.2009.04.002 CrossRefPubMed

46.

Shi Y, Yang D, Zeng Y, Wu W (2017) Risk factors for post-stroke depression: a meta-analysis. Front Aging Neurosci 9:218CrossRefPubMedPubMedCentral

47.

Sharpe M, Hawton K, Seagroatt V, Bamford J, House A, Molyneux A, Sandercock P, Warlow C (1994) Depressive disorders in long-term survivors of stroke: associations with demographic and social factors, functional status, and brain lesion volume. Br J Psychiatry 164:380–388CrossRefPubMed

48.

Sienkiewicz-Jarosz H, Milewska D, Bochyńska A, Chełmniak A, Dworek N, Kasprzyk K, Gałecka K, Szczepańska-Szarej A, Chwojnicki K, Zyluk B, Słowik A, Ryglewicz D (2010) Predictors of depressive symptoms in patients with stroke—a three-month follow-up. Neurol Neurochir Pol 44:13–20. https://doi.org/10.1016/S0028-3843(14)60402-3 PubMedCrossRef

49.

Mitchell AJ, Sheth B, Gill J, Yadegarfar M, Stubbs B, Meader N (2017) Prevalence and predictors of post-stroke mood disorders: a meta-analysis and meta-regression of depression, anxiety and adjustment disorder. Gen Hosp Psychiatry 47:48–60. https://doi.org/10.1016/j.genhosppsych.2017.04.001 CrossRefPubMed

50.

Nickel A, Thomalla G (2017) Post-stroke depression: impact of lesion location and methodological limitations—a topical review. Front Neurol 8:498. https://doi.org/10.3389/fneur.2017.00498 CrossRefPubMedPubMedCentral

Title: Depressive symptoms in stroke patients treated and non-treated with intravenous thrombolytic therapy: a 1-year follow-up study
Authors: Barbara Grabowska-Fudala
Krystyna Jaracz
Krystyna Górna
Izabela Miechowicz
Izabela Wojtasz
Jan Jaracz
Radosław Kaźmierski
Publication date: 01-08-2018
Publisher: Springer Berlin Heidelberg
Published in: Journal of Neurology / Issue 8/2018
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-018-8938-0

At a glance: The STEP trials

Springer Medicine

Depressive symptoms in stroke patients treated and non-treated with intravenous thrombolytic therapy: a 1-year follow-up study

Abstract

Introduction

Methods

Results

Limitations

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Introduction

Methods

Results

Limitations

Conclusions

Please log in to get access to this content

Other articles of this Issue 8/2018

Brain imaging in pregnant women with acute headache

Up-to-date knowledge about the association between multiple sclerosis and the reactivation of human endogenous retrovirus infections

Use of anti-Parkinson medication during pregnancy: a case series

Correlation among olfactory function, motors’ symptoms, cognitive impairment, apathy, and fatigue in patients with Parkinson’s disease

Fatigue, not self-rated motor symptom severity, affects quality of life in functional motor disorders

Isolated acute vestibular syndrome due to presumed primary central nervous system lymphoma involving the dorsal medulla